Novel NSDHL gene variant for congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) syndrome

  1. Ebner Bon Gatus Maceda 1,
  2. Lisa E Kratz 2,
  3. Veronica Marie E Ramos 3 and
  4. Mary Ann R Abacan 1 , 4
  1. 1 Division of Clinical Genetics, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines
  2. 2 Biochemical Genetics Laboratory, Kennedy Krieger Institute, Baltimore, Maryland, USA
  3. 3 Dermatology, University of the Philippines Manila, Manila, Philippines
  4. 4 Institute of Human Genetics, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
  1. Correspondence to Dr Ebner Bon Gatus Maceda; egmaceda@up.edu.ph

Publication history

Accepted:21 Sep 2020
First published:02 Nov 2020
Online issue publication:02 Nov 2020

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

We report a case of a 1-year and 2-month-old girl with clinical features consistent with congenital hemidysplasia with ichthyosis and limb defects syndrome. Sterol analysis from skin flakes revealed increased levels of a mono 4-alpha methyl sterol also seen in plasma as well as the presence of 4-alpha-carboxy-4-methyl-cholest-8(9)-en-3beta-ol and several keto-sterols, which are usually below the limit of detection. This sterol pattern is consistent with abnormal function of the 4-alpha-methylsterol-4-demethylase complex. NSDHL gene testing revealed the presence of a variant of uncertain significance, c.130G>A (p.Gly44Ser). This missense mutation currently is not included in population databases (ExAC no frequency) and has not been reported in individuals with an NSDHL-related condition. Parental studies showed that neither parent carries the NSDHL variant. On this basis, this variant has been reclassified as likely pathogenic. Symptomatic treatment with keratolytic agents, emollients and ketoconazole was initiated.

Background

Congenital hemidysplasia with ichthyosis and limb defects (CHILD) syndrome is a rare X-linked dominant disorder of postsqualene cholesterol metabolism characterised clinically by unilateral limb reduction defects and ipsilateral ichthyosiform skin lesions; chondrodysplasia punctata and visceral anomalies.1 This disorder primarily affects women with prenatal lethality in men. It is caused by a defect in NSDHL, a gene that encodes 3β-hydroxysteroid dehydrogenase (3β-HSD), an enzyme involved in cholesterol biosynthesis.

Cholesterol is a key component of cell membranes and is important in many biosynthetic pathways. A number of disorders of cholesterol biosynthesis, like CHILD syndrome, are known to cause congenital malformation syndromes.

Cholesterol is synthesised from acetate in a series of enzymatic reactions divided into presqualene and postsqualene cholesterol metabolism.2 Postsqualene cholesterol synthesis begins with the conversion of squalene to lanosterol, followed by a series of 19 additional reactions converting lanosterol to cholesterol. 3β-HSD, the enzyme deficient in CHILD syndrome, is one component of the C4 demethylase complex.1 3 A deficiency of this enzyme leads to increased levels of 4α-methylsterols that can be detected in affected skin and cultured cells; however, plasma sterol levels are often normal.

In this report, we present a case of CHILD syndrome with a novel variant in NSDHL. We describe the clinical, radiologic, biochemical and molecular features of this case and discuss clinical management.

Case presentation

We are presented with a 1-year and 2-month-old girl referred for dysmorphologic evaluation. She was born full-term 37 weeks age of gestation via spontaneous vaginal delivery. At birth, the patient was noted to have sharply demarcated erythematous to hyperpigmented patches on the right side of the body, not crossing the midline (right upper extremity, right side of the trunk and abdomen and right lower extremity) and syndactyly.

At 1 week of age, the lesions were noted to increase in thickness, now being erythematous, verrucous plaques with prominent yellow crusting. Areas of weeping were also noted, most extensively on the hands and feet. The patient was subsequently referred to our institution and evaluated by paediatrics, orthopaedics, dermatology and genetics services. She is the youngest of a sibship of four born to a healthy non-consanguineous couple of Filipino descent.

On physical examination, the patient is proportionately small for age with a weight of 5 kg (Z score −3), length of 59 cm (Z score −3) and head circumference of 39 cm (Z score <−2). Anterior fontanel is soft and flat. She has a flat nasal bridge and multiple verrucous plaques with crusting on an erythematous base over the nape. Examination of the chest/cardiac, lungs and abdomen was unremarkable. The right side of the labia majora was erythematous. She has a single transverse palmar crease on the right hand, syndactyly of the second,third, fourth and fifth digits on the right hand, multiple verrucous plaques on the right upper extremity following the lines of Blaschko, hypoplastic nails on the right upper extremity and right lower extremity; syndactyly of the fourth and fifth digits right lower extremity (figure 1). The left side of the body is unremarkable.

Figure 1

Characteristic features of CHILD syndrome in our patient. (A) and (B) show the right upper extremity of the patient with oligosyndactyly. (C) shows the sharp midline demarcation of unilateral ichthyosiform or psoriasiform erythema. (D) and (E) show the right lower extremity of the patient with syndactyly of the fourth and fifth digits. CHILD, congenital hemidysplasia with ichthyosis and limb defects.

Investigations

With note of increase in thickness of the lesions, a 3 mm punch biopsy was obtained from a chest plaque. Histopathologic findings revealed psoriasiform epidermal hyperplasia, spongiosis, papillomatosis, alternating parakeratosis and orthokeratosis with hypergranulosis.

Skeletal survey (figure 2) showed the absence of the middle and distal phalanges of the second and third digits of the hand. There is fusion of the soft tissues of the fourth and fifth phalanges and third metacarpal of the right hand. There is also absence of the metatarsal and phalanges of the third digit of the right foot, and distal phalanx of the second digit of the right foot. Fusion of the soft tissues in the fourth and fifth digits of the right foot was also seen.

Figure 2

Radiographs of our patient with CHILD syndrome. (A) shows the absence of the middle and distal phalanges of the second and third digits of the hand and fusion of the soft tissues of the fourth and fifth phalanges and third metacarpal of the right hand. (B) and (C) show the absence of the metatarsal and phalanges of the third digit of the right foot, and distal phalanx of the second digit of the right foot. Fusion of the soft tissues of the fourth and fifth digits of the right foot. CHILD, congenital hemidysplasia with ichthyosis and limb defects.

Ophthalmologic evaluation was unremarkable. Sterol analysis of plasma showed a mildly increased level 4-alpha methyl 5-alpha cholest-8(9)-en-3ß-ol suggesting an abnormality of cholesterol metabolism involving the 4-alpha-methylsterol-4-demethylase complex. Sterol analysis from skin flakes revealed an increased level of this mono 4-alpha methyl sterol, as well as a significant amount of 4-alpha-carboxy-4-methyl-cholest-8(9)-en-3beta-ol, the presence of which is pathognomonic for a defect in the NSDHL component of the 4-alpha-methylsterol-4-demethylase complex.

In addition, two ketosterols normally below the limit of detection by our analysis were detected. Because the clinical phenotype of our patient was consistent with an NSDHL defect, sequencing of NSDHL was performed (via Invitae), which revealed the presence of a variant of uncertain significance, c.130G>A (p.Gly44Ser). This missense mutation currently is not included in population databases (ExAC no frequency). It has not yet been reported literature in any individual with an NSDHL-related condition. Parental studies showed that neither parent carries this NSDHL variant. Based on the clinical presentation, the functional deficient of the NSDHL demonstrated by abnormal sterol metabolites and the exclusion of parental transmission, this variant has been reclassified as likely pathogenic.

Treatment

Bland emollients, such as white petrolatum, were applied with an addition of a keratolytic lotion (urea 10%) to decrease plaque thickness. Plain sodium soaks were also applied to the weeping areas. Intermittent application of ketoconazole cream once per day provided decrease in waxy scaling, however, crusting and scaling would recur after around 5 days. The patient was maintained on bland emollients and mild cleansers.

Outcome and follow-up

The application of emollients, mild cleansers and ketoconazole provided improvement of the skin lesions. The family underwent pre-test and post-test genetic counselling. They were also introduced to a rare disease patient support group in the Philippines (Philippine Society for Orphan Disorders). The patient is being followed with multidisciplinary services that include General Paediatrics, Dermatology, Developmental Paediatrics, Rehabilitation Medicine, Genetics and Orthopaedics.

DISCUSSION

This report describes a case of a 1-year and 2-month-old girl with clinical features of CHILD syndrome. Although most cases report the affected side to be right, a number of cases also report left.4 5 Contralateral skin involvement, described as minor lesions, was also noted in some cases. In this case, we report right-sided involvement with minor lesions on the left. The ichthyosiform skin lesions in CHILD syndrome can be explained by the deficiency in cholesterol, which is one of the three important lipids in the stratum corneum needed for normal extracellular lamellar bilayer system for barrier function. The lack or deficiency of cholesterol in cell membranes in addition to toxic sterol precursor accumulation may disturb the keratinization process.6

The sharp midline demarcation of unilateral ichthyosiform or psoriasiform erythema is usually present at birth. Lesions classically present with waxy yellow adherent crusts over erythematous plaques following lines of Blaschko.7 The affinity to skin folds such as the axilla, gluteal fold and vulva helps differentiate CHILD syndrome from Inflamed Verrucous Epidermal Nevus.8

Unilateral limb reduction defect, which is also seen in our patient, can also be explained by the deficiency of cholesterol and its metabolites, which play key roles in the regulation of the Sonic Hedgehog signalling.7

The case showed a heterozygous missense mutation on exon 3 of the NSDHL gene c.130G>A (p.Gly44Ser). This specific mutation has not been reported before. In previous reports, non-sense mutations, missense mutations and complete gene deletion have been shown to cause this condition, suggesting a loss of function of the NSDHL protein leads to this birth defect.4 A similar disorder characterised by bilateral ichthyosiform and erythematous skin manifestations and asymmetric skeletal shortening, X-Linked Dominant Conradi Hünermann syndrome, is also caused by a defect of cholesterol biosynthesis.2

The most commonly used therapeutic approach for CHILD syndrome patients includes keratolytic agents such as salicylic acid, urea containing lotions, emollients, corticosteroids and retinoids. However, these treatments only alleviate the epidermal symptoms and do not correct the cholesterol deficiency or toxic metabolite accumulation observed in the syndrome. These agents act to lessen the skin changes, which include hyperkeratosis, inflammation, and epidermal acanthosis through thinning of the epidermis.7 Our patient was managed with locally available keratolytic agents and emollients. Pathogenesis-based therapy with topical lovastatin and cholesterol has been used in previous studies.7 9 However, this is not currently available in the Philippines. Liu et al reported the use of topical ketoconazole, an anti-fungal agent, which inhibits sterol 14α-demethylase (CYP51) leading to decrease in accumulation of toxic metabolites of distal cholesterol metabolism.10 Topical ketoconazole was also tried in this case, but with noted improvement of skin lesions.

Learning points

  • This report highlights the role of clinical presentation, plasma/tissue sterol measurements and molecular studies in the diagnosis and management of congenital hemidysplasia with ichthyosis and limb defects syndrome.

  • This report shows the importance of clinical, functional and parental studies in the evaluation of a variant of unknown significance detected by molecular testing.

  • The sterol analysis of plasma and skin flakes also revealed a unique

Acknowledgments

The authors would like to thank the patient and her family for giving the consent to share this case. The authors would also like to acknowledge Invitae for facilitating the testing of the parents free of charge and Dr Marie Abigail R. Lim for her efforts in the care of the patient.

Footnotes

  • Contributors Each of the authors contributed in writing the manuscript. EBGM is the primary author and has initiated the planning and writing of the paper. LEK participated in the planning, analysis of the sterol analysis and writing of the manuscript specifically in this area. VMER participated in the planning, clinical examination of the dermatologic findings and the writing of the manuscript in this area. MARA participated in the planning, analysis and writing of the manuscript. She is the adviser of main adviser in writing the manuscript as well.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer